TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a target-first and rational molecular glue discovery platform to address difficult to drug disease targets, today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET.

Related Keywords

Massachusetts , United States , Patrick Trojer , Biotechnology Private Company Virtual Symposium On Wednesday , Biomedicines Inc , Chief Executive Officer , Private Company Virtual Symposium , Wednesday September , Biomedicines , Iopharmaceutical Company , Ariana , Rivate Biotechnology Company , Drug Discovery , Disease Targets ,